Sunovion, based in Shrewsbury, MA, is dedicated to improving the health and well-being of people worldwide through innovative treatments in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell and gene therapy.
As a subsidiary of Sumitomo Pharma Co., Ltd., Sunovion drives drug discovery, development, and commercialization with a focus on technology-driven approaches to deliver patient-first solutions and improve outcomes.
Generated from the website